 |
| Research article summary (published 30 Aug 2006): |
[DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?]
(DVO-Leitlinie 2006. Was hat sich geändert in der Diagnostik, Präention und Therapie der Osteoporose?)
Full Abstract
The main changes in the updated DVO guideline 2006 on prevention, diagnosis and treatment of osteoporosis in postmenopausal women and in older men concern the evaluation of individual fracture risks and the selection of medicamentous therapy by means of new thresholds. A 30% risk of osteoporotic vertebral or hip fracture per decade is recommended as the threshold for implementation of pharmacological therapy. Evaluation of the individual absolute fracture risk is based on a combination of the results of densitometry at the lumbar spine and femur, age, gender, and other risk factors that are specifically associated with osteoporosis. Patient's mobility is assessed by carrying out special mobility tests. Further changes seen in the 2006 update of the DVO guideline are therapy proposals taking account of new pharmaceutical developments. New effective medications are rh-PTH (1-34), or teriparatide, strontium ranelate, and ibandronate (bisphosphonate) for monthly oral administration. Minimally invasive operative techniques for use in vertebral fractures in combination with medicamentous antiosteoporosis therapy are also included in the 2006 update of the DVO guideline. Thus, in the 2006 update of the DVO-guideline we have a practice-oriented 53 guideline that is adapted to individual fracture risk and gives recommendations on the prevention, diagnosis and treatment of osteoporosis.
Learn Faster Today Improve your study skills
Author information
Author/s: Fassbender, W J (WJ); Stumpf, U C (UC);
Affiliation: Hospital zum HI. Geist, Akademisches Lehrkrankenhaus der Heinrich-Heine-Universität Düsseldorf, Kempen/Niederrhein. w.j.fassbender(-atsign-)krankenhaus-kempen.de
Journal and publication information
Publication Type: English Abstract; Journal Article; Practice Guideline
Journal: Zeitschrift für Rheumatologie (Z Rheumatol), published in Germany. (Language: ger)
Reference: 2006-Sep; vol 65 (issue 5) : pp 364-6, 368-9
Dates: Created 2007/02/23; Completed 2007/03/30; Revised 2007/11/15;
PMID: 16947038, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- [Osteoporosis priority: Reduce the number of fractures]
29 Sep 2006 - [Osteoporosis in the elderly]
29 Sep 2006 - Prevention of osteoporotic fractures in the elderly. 30 Oct 2005
- [The necessity of cost-effectiveness analysis in osteoporosis] 11 Jun 2007
- [Osteoporosis: Optimizing treatment strategy] 29 Sep 2006
- Effects of osteoporosis medications on bone quality. 26 Nov 2006
- [Advances in the field of osteoporosis] 13 Oct 2007
- Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. 30 Mar 2008
- Osteoporosis at presentation of childhood ALL: management with pamidronate. 29 Sep 2005
- Anabolic skeletal therapy for osteoporosis.
30 Jul 2006
Related Article Map
9/29/2005
3/30/2008
Higher Relevance Score (26)
Lower Relevance Score (19)
Legend: - FREE Full text Article. - Abstract only. - Title only. More help.
See a large map of 100+ related articles.